MXPA06012887A - Derivados ciclopeptidos con actividad de antiintegrina. - Google Patents

Derivados ciclopeptidos con actividad de antiintegrina.

Info

Publication number
MXPA06012887A
MXPA06012887A MXPA06012887A MXPA06012887A MXPA06012887A MX PA06012887 A MXPA06012887 A MX PA06012887A MX PA06012887 A MXPA06012887 A MX PA06012887A MX PA06012887 A MXPA06012887 A MX PA06012887A MX PA06012887 A MXPA06012887 A MX PA06012887A
Authority
MX
Mexico
Prior art keywords
phe
gly
arg
asp
group
Prior art date
Application number
MXPA06012887A
Other languages
English (en)
Spanish (es)
Inventor
Maria Ornella Tinti
Sergio Penco
Claudio Pisano
Giuseppe Giannini
Loredana Vesci
Alma Dal Pozzo
Ni Minghong
Original Assignee
Sigma Tau Ind Farmaceuti
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Ind Farmaceuti filed Critical Sigma Tau Ind Farmaceuti
Publication of MXPA06012887A publication Critical patent/MXPA06012887A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/12—Cyclic peptides with only normal peptide bonds in the ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pain & Pain Management (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
MXPA06012887A 2004-05-13 2005-05-04 Derivados ciclopeptidos con actividad de antiintegrina. MXPA06012887A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT000239A ITRM20040239A1 (it) 2004-05-13 2004-05-13 Derivati ciclopeptidici ad attivita' antintegrine.
PCT/IT2005/000262 WO2005111064A1 (en) 2004-05-13 2005-05-04 Cyclopeptide derivatives with anti-integrin activity

Publications (1)

Publication Number Publication Date
MXPA06012887A true MXPA06012887A (es) 2007-02-15

Family

ID=34968013

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA06012887A MXPA06012887A (es) 2004-05-13 2005-05-04 Derivados ciclopeptidos con actividad de antiintegrina.

Country Status (23)

Country Link
US (1) US20070178045A1 (enExample)
EP (1) EP1751176B1 (enExample)
JP (1) JP2008500971A (enExample)
KR (1) KR20070012524A (enExample)
CN (1) CN1953990A (enExample)
AR (1) AR048957A1 (enExample)
AT (1) ATE460426T1 (enExample)
AU (1) AU2005243418A1 (enExample)
BR (1) BRPI0510985A (enExample)
CA (1) CA2562576A1 (enExample)
CY (1) CY1110039T1 (enExample)
DE (1) DE602005019876D1 (enExample)
DK (1) DK1751176T3 (enExample)
ES (1) ES2340862T3 (enExample)
HR (1) HRP20100301T1 (enExample)
IT (1) ITRM20040239A1 (enExample)
MX (1) MXPA06012887A (enExample)
PL (1) PL1751176T3 (enExample)
PT (1) PT1751176E (enExample)
RS (1) RS51300B (enExample)
SI (1) SI1751176T1 (enExample)
TW (1) TW200606178A (enExample)
WO (1) WO2005111064A1 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2436109T3 (es) * 2006-02-09 2013-12-27 Belrose Pharma Inc. Conjugados poliméricos de múltiples brazos de 7-etil-10-hidroxicamptotecina para el tratamiento del cáncer de mama, del cáncer colorrectal, del cáncer de páncreas, de ovario y de pulmón
EP1961759A1 (en) * 2007-02-21 2008-08-27 Universita'degli Studi Di Milano Integrin targeted cyclopeptide ligands, their preparation and use
TWI474819B (zh) 2012-05-15 2015-03-01 國立成功大學 調控物及含有該調控物之醫藥組合物
JP2016515120A (ja) * 2013-03-15 2016-05-26 バイオジェン・エムエイ・インコーポレイテッドＢｉｏｇｅｎ ＭＡ Ｉｎｃ． 抗アルファｖベータ５抗体を用いた急性腎損傷の治療及び予防
CN103588863B (zh) * 2013-11-15 2016-08-17 苏州强耀生物科技有限公司 Rgd环肽合成制备工艺
WO2022183360A1 (en) * 2021-03-02 2022-09-09 Tsao Yeou Ping Short synthetic peptide and their uses for treating dry eye disease

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4310643A1 (de) * 1993-04-01 1994-10-06 Merck Patent Gmbh Cyclische Adhäsionsinhibitoren
US5449761A (en) * 1993-09-28 1995-09-12 Cytogen Corporation Metal-binding targeted polypeptide constructs
US6027711A (en) * 1995-06-07 2000-02-22 Rhomed Incorporated Structurally determined metallo-constructs and applications
DE19725368A1 (de) * 1997-06-16 1998-12-17 Merck Patent Gmbh Cyclische Adhäsionsinhibitoren und deren Verwendung für bildgebende Verfahren
ITRM20040240A1 (it) * 2004-05-13 2004-08-13 Ist Naz Stud Cura Dei Tumori Camptotecine coniugate in posizione 7 con antagonisti delle integrine.
ITRM20040242A1 (it) * 2004-05-13 2004-08-13 Ist Naz Stud Cura Dei Tumori "7-t-butossiimminometilcamptotecina coniugata in posizione 20 con antagonisti delle integrine.

Also Published As

Publication number Publication date
RS51300B (sr) 2010-12-31
HRP20100301T1 (hr) 2010-06-30
ES2340862T3 (es) 2010-06-10
WO2005111064A8 (en) 2006-02-09
PT1751176E (pt) 2010-05-12
JP2008500971A (ja) 2008-01-17
SI1751176T1 (sl) 2010-06-30
PL1751176T3 (pl) 2010-08-31
KR20070012524A (ko) 2007-01-25
EP1751176A1 (en) 2007-02-14
CY1110039T1 (el) 2012-05-23
TW200606178A (en) 2006-02-16
AR048957A1 (es) 2006-06-14
ATE460426T1 (de) 2010-03-15
CN1953990A (zh) 2007-04-25
US20070178045A1 (en) 2007-08-02
EP1751176B1 (en) 2010-03-10
DK1751176T3 (da) 2010-06-14
ITRM20040239A1 (it) 2004-08-13
BRPI0510985A (pt) 2007-12-04
CA2562576A1 (en) 2005-11-24
DE602005019876D1 (de) 2010-04-22
WO2005111064A1 (en) 2005-11-24
AU2005243418A1 (en) 2005-11-24

Similar Documents

Publication Publication Date Title
ES2349879T3 (es) Peptidomiméticos fijados sobre patrón.
JPH0364514B2 (enExample)
JPH02212434A (ja) レトロウイルスプロテアーゼインヒビターとしてのペプチドアイソスターの使用
Samanen et al. Chemical approaches to improve the oral bioavailability of peptidergic molecules
CN1953989B (zh) 作为细胞抑制剂的在7位与环肽缀合的喜树碱
EP1751176B1 (en) Cyclopeptide derivatives with anti-integrin activity
SK173599A3 (en) Cyclic azapeptides with angiogenic effect
US20100093612A1 (en) Integrin targeted cyclopeptide ligands, their preparation and use
EP1539803B1 (en) Fluoro-alkyl-cyclopeptide derivatives having anti-integrin activity
CN107602450A (zh) 氨基酸骨架类新型cxcr4拮抗剂及其制备与生物医学应用
JPH06306096A (ja) ペプチド誘導体及びその用途
CA2405724C (en) Substance p analogs for the treatment of cancer
SK62998A3 (en) New lh-rh antagonists with improved effectiveness
JP2918746B2 (ja) ペプチド誘導体およびその用途
JP3190758B2 (ja) ペプチド誘導体及びその用途
JP3190765B2 (ja) ペプチド誘導体及びその用途
HK1104045A (en) Cyclopeptide derivatives with anti-integrin activity
MXPA06012885A (es) 7-t-butoximinometilcamptotecina conjugada en posicion 20 con antagonistas de integrina.
TW379216B (en) Novel LH-RH antagonists having improved action, harmaceutical composition comprising the same and process for preparing the same
CN119823253A (zh) Shf类似物、预防和/或治疗肿瘤的药物组合物与应用
JPH0717999A (ja) ペプチド誘導体及びその用途
Parente Diketopiperazines as scaffold for the synthesis of new compounds modulating protein-protein interactions and functions
WO2004069861A1 (de) Peptidische sulfonamide
JPH06228189A (ja) ペプチド誘導体およびその用途
JPH07233084A (ja) 化学療法剤効果増強剤

Legal Events

Date Code Title Description
FG Grant or registration